Ranbaxy launches acne drug in US
REUTERS - Ranbaxy Laboratories Ltd (RANB.NS), India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.
The drug is in-licensed from Cipher Pharmaceuticals Inc (DND.TO), said Ranbaxy, controlled by Japan's Daiichi Sankyo Co (4568.T), on Monday. (Reporting by Kaustubh Kulkarni in Mumbai)
- Tweet this
- Share this
- Digg this
India is targeting up to $1 billion of private investment by 2017 to build rail lines linking ports and national networks to ease growing congestion, which has delayed coal imports for power plants and contributed to a power supply crisis. Full Article
Hyundai Motor, Kia Motors lift 2014 global sales target on China, emerging markets Full Article